Cancer News

Recent advances in neuro-oncology have spotlighted focused ultrasound (FUS) as a promising tool for diagnosing and treating aggressive brain tumors. This innovative technology offers a non-invasive...

Recent advancements in cancer treatment have led to the exploration of High-Intensity Focused Ultrasound (HIFU) as a potential therapy for renal cell carcinoma (RCC), particularly in patients...

The recent announcement from the Trump administration regarding new regulations for cancer registries has raised significant concerns among LGBTQ+ health advocates and researchers. Starting in 2026,...

Recent advancements in breast cancer treatment were highlighted at the San Antonio Breast Cancer Symposium (SABCS), where researchers unveiled promising findings about giredestrant, a next-generation...

The landscape of breast cancer treatment is evolving with the introduction of AidaBreast™, a groundbreaking multi-omic test designed to accurately predict locoregional recurrence risk and assess the...

In a promising development for oncology, Novastra Therapeutics has initiated a Phase 1b clinical trial for OAP-1, a novel immune reprogramming cancer therapy aimed at patients with advanced solid...

Recent developments in cancer treatment have shed light on an innovative immunotherapy, OAP-1, being tested by Novastra Therapeutics. This novel approach has shown promising early results in patients...

Recent advancements in artificial intelligence (AI) are set to transform the landscape of cancer detection, particularly in gastrointestinal cancers. Researchers from Chulalongkorn University have...

The San Antonio Breast Cancer Symposium (SABCS) 2025 is set to showcase groundbreaking research from Roswell Park Comprehensive Cancer Center, where a diverse group of experts will present their...

Researchers at The University of Texas MD Anderson Cancer Center have unveiled a groundbreaking antibody therapy known as 77A, presenting a significant advancement in the battle against...

Recent findings presented at the American Society of Hematology (ASH) annual meeting highlight a groundbreaking antibody therapy that may significantly advance the treatment of multiple myeloma, a...

Recent developments in cancer treatment continue to inspire hope, particularly for patients battling difficult forms of the disease. At the 67th American Society of Hematology (ASH) Annual Meeting,...

Recent research presented at the 2025 American Society of Hematology (ASH) meeting has unveiled groundbreaking insights into how the structure of DNA within our cells can influence the onset of...

Recent findings from the ACCESS trial have revealed a significant breakthrough in the field of stem cell transplantation for patients with blood cancers, such as leukemia. Traditionally, successful...

The New York State Department of Health has granted approval for Wren Laboratories' NETest 2.0, a next-generation blood test designed to detect and monitor neuroendocrine tumors (NETs). This...

Recent research from UCLA has shed light on the role of a crucial protein, NBCn1, in helping breast cancer cells thrive in challenging environments. By understanding how this protein operates,...

Recent findings from Cedars-Sinai Cancer reveal significant progress in the fight against liver cancer, coupled with exciting developments in artificial intelligence (AI) that promise to enhance...

Recent findings from the STELLAR clinical trial have emerged as a beacon of hope for individuals battling grade 3 astrocytoma, an aggressive form of brain cancer. Conducted by the Huntsman Cancer...

In a significant boost for cancer research and treatment, Rush University System for Health has received its largest philanthropic donation to date. The Harold B. Smith Foundation’s generous...

The American Cancer Society (ACS) recently announced significant updates to its cervical cancer screening guidelines, an advancement that could reshape the landscape of early detection and treatment...